ingredientpharmTAPs. The safe and easy way to multi-particulate dosage forms
Multi-particulate dosage forms have striking advantages compared to monolithic dosage forms, such as:
- low variability of gastric emptying
- low dependency on nutrition state
- low risk of localized high drug concentrations in the GI
- reduced risk of sudden dose dumping
- lower intra- and inter-individual variability
- high control on time and place of drug delivery
This means firstly higher safety and secondly better compliance for your patients, and added-value for your products.
Send a request!
Satisfied partners
TAP is a great offering for our clients that have a drug that shows pH dependent solubility and requires an acidic environment to improve solubility, release, and absorption. The TAP pellets can do a great job of creating the acidic microenvironment required to make their drug successful.
APIs with poor solubility in alkalic media, like in the intestine, sometimes need a kick with a small acidic environment and we are happy to support our customers with TAP® as excipient for this dilemma.
Our project partners love to work with TAPs, as they accelerate the dissolution rate of weakly basic drugs creating the best in-situ micro-environment conditions. You get TAPs in diverse sizes – perfect for multi-particulate formulations!
Formulation Support
The development of solid dosage forms with tartaric acid pellets is one of Glatt Pharmaceutical Services’ specialty, with focus on complex formulations and vast expertise for multiparticulate systems. The development and manufacturing centers with FDA and EU-GMP certification are well equipped for all your requirements. New technologies are in charge for the realization of your product ideas. Also for demanding ingredients.
- Sites and cGMP facilities in Germany & USA
- Strong core competence
- Solution oriented
- Flexible setup
- Full service
Product information: Tartaric Acid Pellets
| Product, standard sizes | Size | Mesh size | |
| TAP 200 | 100-355 µm | 150/50 | more details |
| TAP 400 | 300-500 µm | 55/35 | more details |
| TAP 500 | 400-600 µm | 42/30 | more details |
| TAP 600 | 500-700 µm | 35/25 | more details |
| TAP 700 | 600-800 µm | 30/22 | more details |
| Product, narrow sizes | |||
| TAP 300-425 | 300-425 µm | 55/40 | more details |
| TAP 425-500 | 425-500 µm | 40/35 | more details |
| TAP 425-600 | 425-600 µm | 40/30 | more details |
| TAP 425-600 PSD | 500-600 µm | 35/30 | more details |
| TAP 500-600 | 500-600 µm | 35/30 | more details |
| TAP 700 PSD | 600-710 µm | 30/25 | more details |
| TAP 850-1000 | 850-1000 µm | 20/18 | more details |
TAPs are best solution for weakly basic API. No fitting pellet sizes found? Not the right material?
ingredientpharmCase Studies & Application notes
ingredientpharm
https://tapellets.com/wp-content/uploads/2022/06/video-icon.jpg
469
835
Bastian Arlt
https://tapellets.com/wp-content/uploads/2021/03/ingredientpharm-700x240-1-300x103.png
Bastian Arlt2022-09-21 10:44:552022-09-21 12:35:29Dissolution of Tartaric Acid Pellets
Glatt
https://tapellets.com/wp-content/uploads/2022/07/parameter-space.jpg
772
823
Bastian Arlt
https://tapellets.com/wp-content/uploads/2021/03/ingredientpharm-700x240-1-300x103.png
Bastian Arlt2022-07-05 14:43:022022-07-05 14:57:31Water-insoluble weakly basic actives on tartaric acid beads – a DoE case study
https://tapellets.com/wp-content/uploads/2022/06/hand-capsule-pixabay-free-3632914_1920.jpg
1280
1920
Bastian Arlt
https://tapellets.com/wp-content/uploads/2021/03/ingredientpharm-700x240-1-300x103.png
Bastian Arlt2022-06-15 14:50:362022-07-05 14:56:37Analytics of Dipyridamole Modified Release Capsules
linkedin
